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Introduction: Unintended pregnancy is a public health issue, with young women in
their late teens and early 20s at highest risk. Multiple approaches to increasing con-
traception access have been implemented, including adoption of statewide pharma-
cist prescribing legislation in multiple states. Indiana does not currently have such
legislation in place. The objective of this study was to identify how women at risk for
unintended pregnancy in central Indiana perceive pharmacist prescribing of
contraception.
Study Design: Qualitative, one-on-one semi-structured interviews.
Methods: Purposive, convenience sampling of eligible women 18 to 29-years-old who
live in Indiana was used. Recruitment occurred via printed flyers placed in public loca-
tions that were not focused on health care, free classified online advertisements, and
electronic flyers within Facebook social groups relevant to the study population. Inter-
views were conducted via telephone until thematic saturation was achieved. Partici-
pant demographics, baseline characteristics, current and past barriers to obtaining
contraception, and perception of a pharmacist contraception prescribing model were
collected. Interview transcripts were coded in an iterative manner with qualitative data
analysis software (MAXQDA, Version 12) until consensus was achieved.
Results: Fourteen women completed the study. Four primary themes emerged
encompassing accessibility, communication, pharmacist attributes, and payment.
Thirteen participants would personally utilize a pharmacist prescribing contraceptive
service and all stated that this service would be beneficial for other women. Of those
women expressing a preference (n = 7), a female pharmacist would be preferred for
service delivery. Participants expressed concerns related to access by minors, skills
and training of the pharmacist, and environment within the pharmacy.
Conclusions: Women in Indiana desire broader access to contraception. Efforts
should be made at the individual pharmacist-provider level and statewide to explore
strategies to increase access. Resources should be allocated to the creation of proto-
cols for pharmacist prescribing within Indiana and other states.
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1 | INTRODUCTION
Because unintended pregnancy is a public health crisis, it is a target of
the Healthy People 2020 (HP2020) initiative.1 Many of the Family
Planning objectives of HP2020 aim to decrease unintended pregnancy
through improved access to contraception. Young women in their late
teens and early 20s exhibit the highest rates of unintended preg-
nancy; of these, 91% of pregnancies are among adolescents, and 59%
of pregnancies for women age 20-24 years are unwanted or mis-
timed.2 However, when barriers to access to same-day contraception
are removed, unplanned pregnancy rates decrease by 20%-40%.3,4
One approach to increasing access to contraception is to provide
it where adolescents and young women are already shopping, such as
a community pharmacy within the county in which they reside.5 It has
been shown that more than half of women visit a pharmacy at least
once per month. In many states, expansion of the pharmacist prescrib-
ing model has been recognized by policy-makers through statewide
legislation, and this could provide an additional method for enhancing
access.6-8 Overall, perceptions of pharmacist prescribing for contra-
ception is positive—numerous studies have shown that most women,
community pharmacists, student pharmacists, and other health care
providers are supportive of this expanded role.9-14
The basic process for obtaining contraception via this mecha-
nism is:
1. A patient presents to the community pharmacy, completes a self-
administered questionnaire to screen for medical contraindica-
tions, and her blood pressure is assessed.
2. A pharmacist with special training recommends appropriate
contraceptive(s) based on responses to the questionnaire, patient
preferences, and local statutes. If the patient is ineligible for a
pharmacist prescribed method, or if she requests a product that is
unavailable in the pharmacy, the pharmacist refers the patient to
an appropriate provider for further evaluation.
3. Once a contraceptive has been selected, the pharmacist prescribes
the medication and provides counseling that includes instructions
for initiation, adherence, management of side effects, and expec-
tations for follow-up visits.
Within Indiana, the rate of unintended pregnancy reached 49% in
2010 (55 000 pregnancies), resulting in an estimated 35 200 births
(64%), 11 000 abortions (20%), and 8800 miscarriages (16%).15 State-
wide legislation allowing pharmacists to prescribe contraceptive medi-
cations does not currently exist in Indiana or in the majority of other
states, however there is a broader form of pharmacist prescribing
through collaborative drug therapy management (CDTM) that pro-
vides the framework for creating a similar model. CDTM is defined as
“a collaborative practice agreement between one or more physicians
and pharmacists wherein qualified pharmacists working within the
context of a defined protocol are permitted to assume professional
responsibility for a variety of functions, including patient assessment,
ordering drug therapy-related laboratory tests, and selecting,
initiating, monitoring, continuing, and adjusting drug regimens.”16,17
As of 2016, 48 states including Indiana allow creation of CDTMs for
the management of a variety of disease states (eg, diabetes or hyper-
tension), making pharmacist prescribing of hormonal contraceptives
possible.18 As a first step towards exploring this potential for an
expanded role, the objective of this study was to identify how women
at risk for unintended pregnancy in central Indiana perceive pharma-
cist prescribing as a method for obtaining contraception.
2 | METHODS
2.1 | Design
Participant interviews were conducted to gather information from
women across central Indiana. One-on-one semi-structured inter-
views were completed and recorded, using an interview guide devel-
oped specifically for this study. Exempt status was received from the
Human Research Protection Program at Purdue University.
2.2 | Participant recruitment
Purposive, convenience sampling was used to select participants
residing within central Indiana. Central Indiana was selected as the
recruitment site based on the large population of young women, abil-
ity to complete timely in-person interviews, and increased demo-
graphic diversity of potential participants. Eligible participants were
females, aged 18 to 29-years-old, and able to read, speak, and under-
stand English or Spanish. Women not meeting these inclusion criteria
were excluded.
To facilitate recruitment, printed flyers were posted in public areas
around central Indiana such as libraries, coffee shops, and community
colleges. Flyers were not placed in locations focused on health care,
such as pharmacies and clinics, in an attempt to recruit young women
that may not routinely access health care services. In addition, a free
classified advertisement was posted on Craigslist for Indiana and
NUVO, a local independent alternative-newspaper, and electronic
flyers were posted to various Facebook social groups relevant to the
study population. Participants were recruited until thematic saturation
was achieved. Saturation was monitored throughout recruitment and
by the tenth interview, no new themes were identified. Four addi-
tional interviews had been scheduled prior to determining thematic
saturation, therefore all participants were interviewed to confirm that
no new themes were emerging.
2.3 | Setting
One of two investigators (AM, NO) completed the one-on-one inter-
view with participants at a time that was mutually agreed upon
between the investigator and participant. Participants were given the
option of completing the approximately 30-minute interviews face-
to-face or via telephone.
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2.4 | Data collection
To ensure face validity of the question guide before completing inter-
views with study participants, each investigator completed at least
two pilot interviews. At the beginning of each interview, investigators
collected participant demographics (eg, age, race) and baseline charac-
teristics (eg, current birth control use, past birth control use, current
health conditions, health insurance status). The investigator then
explored participants' current and past barriers to obtaining contra-
ception, accessing their preferred pharmacy, experiences with their
pharmacy and pharmacist, and perception of a pharmacist prescribing
model for contraception (Supporting Information in Data S1). Partici-
pants could choose to skip any item that they were uncomfortable
discussing. After obtaining participant permission, the investigators
recorded all interviews. Recordings were transcribed verbatim using a
Health Insurance Portability and Accountability Act (HIPAA)-
compliant service (Infraware, Terre Haute, Indiana) to ensure correct
recall of statements, and to compile and de-identify information.
2.5 | Data analysis
To identify themes in participant responses, the interview transcripts
were coded in an iterative manner through use of qualitative data
analysis software (MAXQDA, Version 12, Berlin, Germany). Two
investigators (AM, NO) independently coded all transcripts and dis-
cussed the rationale for any differences until consensus was achieved.
If consensus could not be achieved, a third investigator was available
to settle any discrepancies, but was not utilized. Recruitment closed
once investigators agreed that thematic saturation had been attained.
3 | RESULTS
Fourteen women participated in the study; all opted for a telephone
interview. On average, they were 25-years-old (range, 20–29), took
an average of two medications per day (range, 0–15), and six were
currently using a hormonal contraceptive (Table 1; Figure 1).
Four primary themes emerged, encompassing accessibility, com-
munication, pharmacist attributes, and payment. Each primary theme
had three additional subthemes that were identified. Some themes
and subthemes were predefined, while others emerged during analy-
sis. Additional illustrative examples highlighting these themes and sub-
themes can be found in Table 2.
3.1 | Theme 1: Accessibility
Within the theme of accessibility, many women commented about
the current practice model of accessing a health care provider to obtain
TABLE 1 Participant demographics
Characteristic n = 14
Age, mean (range) 25 (20–29)
Race
Black or African American, n (%) 1 (7.1)
White, n (%) 11 (78.6)
Prefer not to answer, n (%) 2 (14.3)
Ethnicity
Hispanic, n (%) 4 (28.6)
Non-Hispanic, n (%) 10 (71.4)
Current daily medications, mean (range) 2 (0–15)
Health insurance for prescription medications
Yes, n (%) 11 (78.6)
No, n (%) 3 (21.4)
Health insurance for birth controla
Yes, n (%) 8 (61.5)
No, n (%) 5 (38.5)
aNote: n = 13.
F IGURE 1 Participant birth
control use
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TABLE 2 Themes and Representative Quotations
Primary theme Subtheme Quotations
Accessibility Current practice
model
“I was just there for my six-week normal check. I didn't really want to be put on birth control right away
because I kind of wanted my body to try to get back to normal before I got put back on it. My doctor
strongly recommended it, so at that point in time they put me on the mini-pill or whatever. So I had to
get checked by them and then I think I have a year supply. Then I will go back to get an exam again.”—
Participant 8
“They have two separate offices, and I was scheduled at one and I showed up, and they were like, you
are not scheduled for this office, so I had to drive all the way across town to a different office when I
was told the opposite, so that was kind of a pain.”—Participant 9
Wait times “Sometimes, like the prescription will be wrong and you have to wait for the OB to call you back, and a
lot of phone tag”—Participant 7
“They [gynecologists] are really hard to get hold of. They don't really answer the phone that often and
they don't tend to call you back, so it takes a while to get an appointment there.”—Participant 9
Pharmacist
prescribing model
“I honestly think especially in rural areas where there are not doctors, or not enough doctors, like where
I live right now there are not enough family doctors, that service would probably be used a lot.”—
Participant 5
“I think it is very convenient and I guess very convenient for other people that they have easier access to
birth control as opposed to having to schedule an appointment with the physician and maybe wait if
they weren't able to get in right away and it allows for access to that right away which would be
helpful.”—Participant 13
Parental consent “I think one day ‘What if my daughter has to use this?’, like if it can be without a parent's knowledge, but
I did that one time, you know?”—Participant 1
“A lot of young people might [not] want to go to the gynecologist necessarily, or they never have and so
they are kind of nervous, but they still want the access to the birth control and they want to be safe,
or they might need it for, who knows… a lot of reasons, so I think it would help young people because





“… in a little bit of a private secluded area so that they are not in a store that they frequent often,
especially in case they were to see someone they knew or whatnot. So kind of just maybe in a remote
area.”—Participant 13
“Like a semi-closed off area where, you don't have other people listening to your conversation, because
that's kind of a private, personal thing.”—Participant 14
Interaction with other
provider(s)
“I would prefer that [the pharmacist talk to other healthcare providers]. Then I think it would be safer if a
doctor could review it and make the final call, at least knew about it ahead of time.”—Participant 5
“Maybe some sort of release of information with your OB… that way they maybe could have access to
medical records if they have any concerns or questions… or could review those types of things prior to




“As awkward and embarrassing as that is, they were pretty up front about it, and ‘Scar tissue and stuff
makes things uncomfortable, and having kids changes your anatomy’ and stuff like that. So, they were
like ‘Well maybe you should look into the different birth control options if it is discomforting you.’”—
Participant 7
“And someone who is professional and is willing to lay out all the pros and cons of different options and
health risks of different options and someone that seems comfortable in what they are doing by
providing you with birth control.”—Participant 14
Pharmacist
Attributes
Skills and training “Somebody with multiple health problems, the pharmacists generally aren't as knowledgeable about
those, and it could cause a lot of interactions with the symptoms I currently have… my other health
problems. And I feel like a pharmacist wouldn't be knowledgeable enough to address that and might
prescribe something to somebody that could cause more harm than good.”—Participant 5
“I guess the only hesitation would be the pharmacist isn't necessarily trained in that area, so I guess I
would be a little hesitant about their knowledge base and their ability to discern between different
kinds of birth control and what would be best for that. I don't really know what the separate
qualifications are, from what I have heard it is mostly just personal preference between the different
kinds of birth control. I would be concerned about the previous education of my pharmacist to make
them qualified to make that decision.”—Participant 12
Personality and
demeanor
“Probably one that is patient and has time to answer my questions if I should have them.”—Participant 3
“Someone that is warm and friendly about it and very open and just patient and understanding, because,
some people might be embarrassed or they just might be kind of timid to ask questions, so that would
be, something to be like, ‘Oh, okay’, just that warm environment for that person to open up and be
okay.”—Participant 7
(Continues)
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a new or refilled birth control prescription. Participants expressed
frustrations with the need for scheduled appointments, required phys-
ical examinations, and other barriers such as obtaining childcare to
attend visits.
“It's a little bit harder [to coordinate] because my
daughter is autistic, so I have been trying to find a
babysitter that knows how to handle some of the
challenges that come with that. So, she did have to
come with me, but they were pretty nice about the
entire situation, they were very understanding, and
she was relatively behaved that day, so… that hel-
ped.”—Participant 7
A somewhat related, yet separate subtheme of wait times evolved
throughout data analysis. Women were often frustrated with setting
up and attending appointments, as well as receiving products from
the pharmacy.
“And then also, the wait times… because when I was able
to get my diaphragm in the past… there was a special
order, like wait time, so that was also inconvenient. So
yeah, child care for sure and then wait time for picking it
up from the pharmacy.”—Participant 14
When asked for their perceptions of a pharmacist prescribing
model, 13 participants indicated they would personally utilize a phar-
macist prescribing contraceptive service, and all participants stated
that this service would be beneficial for other women. Many women
perceived this service as convenient due to a lack of scheduled
appointments and extended hours of availability, decreased waiting
time, and increased health care resources.
“I would love that. I would love not having to call over
and over again trying to get into my gynecologist every
year. I also would skip the whole waiting process at the
gynecologist. My pharmacy is closer than both my gyne-
cologist's offices, so that would be positive. I don't… I'm
young and I don't have any other health problems and I
don't have a lot of concerns or things that I would need
to talk to the gynecologist about, so it would just be… it
would save me time and effort to go get something like
that. I honestly… I would love that so much to just be able
to go in there and talk to them and get a prescription that
day.”—Participant 9
Within accessibility, the idea of parental consent emerged. Some
participants viewed this model as an option for young women that
might not be comfortable disclosing to their parents that they are
TABLE 2 (Continued)
Primary theme Subtheme Quotations
Sex “I would probably prefer a female, that is on birth control, just because they understand the side
effects a little bit more.”—Participant 6
“I think that it would be most comfortable for myself as well as other women to have a female
pharmacist doing this. I know I am a nurse and I know that I get that question a lot. It seems like
most females prefer when we do referrals to OB/GYN they prefer a female. So I think that maybe
that would put more people at ease or more women at ease when discussing different things that
there are concerns about and any issue getting birth control prescription from a pharmacist.”—
Participant 13
Payment Insurance coverage “It would depend on how much it was, because there is that convenience factor, but it's like how much
are you willing to pay for the convenience factor. And it also depends would it just be a copay through
your insurance? Would the insurance cover it? Is it a non-insurance thing?”—Participant 7
“Well if they were able to bill for it, that would obviously be better because they are providing a service,
but if they weren't, it would stay off my insurance and that would be a positive too.”—Participant 12
Willingness to pay “I would expect that there would be some sort of cost involved. Yeah, I wouldn't think that it would be
free. I mean, it would be nice if it was free, but if there was a cost, that wouldn't discourage me from
using that.”—Participant 10
“You are paying for the convenience of it and you are paying for not having to go to your doctor. Your
doctor costs money anyway, it is just your insurance will sometimes cover it, but I would appreciate
the service so I wouldn't mind paying for it.”—Participant 12
Cost comparison to
provider visit
“Well I mean if it was a small fee, I think that is… I mean they have to get paid too, so that wouldn't
bother me. I mean if it's going to be $80 like it would be for an office visit, then I might as well just get
everything done at the same place. If it was like $15 or $20, then I could see the value of it”—
Participant 8
“I would probably not want to pay as much as I would pay for a doctor's appointment, but I understand
that it would be some of that pharmacist's time, so, you know, no such thing as a free lunch and all of
that. I am sure that I could understand there being some kind of cost, but since it would not be quite
as involved as an appointment with a medical doctor in an office with an exam, I would expect it to be
less.”—Participant 14
Abbreviations. GYN, gynecologist; OB, obstetrician.
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seeking birth control, while other participants expressed concerns that
young women might be able to do just that.
“I feel like under the age of 16 they should have
some sort of parental consent or at least have some-
thing like that or somebody over the age of 18 that
they would have, but somebody that is there,
involved in that, because it is a drug and I feel like
parents should… or somebody… you know, even if it
is an aunt or uncle or somebody that they trust that
is not their parent, somebody should know the side
effects and things like that and understand them,
because I feel like even when I was taking it under
16, I didn't understand the side effects and things
like that.”—Participant 6
3.2 | Theme 2: Communication
Multiple concepts related to the primary theme of communication
emerged throughout the interviews. A general concern raised by some
participants was the environment within the pharmacy for a confidential
discussion.
“Well I would like more of a secluded area talking about
things, because I don't want the whole world [to] know I
am on certain medications. So kind of doing it in a more
secluded area versus just the consultation area that they
have at the counter.”—Participant 8
The way in which the pharmacist might have an interaction with
other provider(s) was also discussed.
“I guess birth control can interact with a lot of different
medications like antibiotics and stuff. I would want my
other healthcare practitioners to know. The more people
that know the more it becomes a privacy thing as well. So
I guess I wouldn't mind them sharing the information
because it is important to my health care, but I would just
be concerned about the level of privacy my other health
care physician has.”—Participant 12
Participants discussed the factual and non-judgmental approach of
a pharmacist in a positive way as it relates to discussing sensitive
topics, however it was also viewed as a barrier to developing a more
in-depth relationship.
“Then seeing a pharmacist you have a million things that
you have to do at a time, at least from what it looks like.
So whenever you ask a pharmacist questions most of the
time, they are very cut to the point, because they have a
million other things to be doing. So just having a rapport
with that person I think would be helpful.”—Participant 8
3.3 | Theme 3: Pharmacist attributes
Participants were asked a series of questions about pharmacists
that would make them most comfortable utilizing this type of ser-
vice. More often than not, participants voiced questions and con-
cerns related to the skills and training of the pharmacist who
would be performing this type of service, particularly if they had
multiple chronic conditions or took multiple daily prescription
medications.
“I think I would like if there were some type of continuing
education or some type of training program. I guess if it is
going to be implemented nationwide, it would be in the
pharmacy school curriculum. Like for all the pharmacists
that graduate before that, I think there should be some
type of certification and just to get the information before
they start doing this. I guess I would look for something
like that. Like if you are newly out of school curriculum or
someone who has gone back and like studied it all for the
requirement.”—Participant 12
The personality and demeanor of the pharmacist providing the ser-
vice was also an important consideration.
“…and calming and understanding, they come off well
educated regarding the several different types of birth
control and if there are questions regarding different
brands and side effects and things like that. The
patient would be comfortable asking and knowing
that they are being provided adequate information.”—
Participant 13
The sex of the pharmacist was an important consideration for
most women. Of those who expressed a preference (n = 7), a female
pharmacist was preferred. The remaining participants did not mention
the sex of the pharmacist as impacting their perceptions.
“I think that there's always, especially when you are see-
ing someone for birth control, it is sort of nice to have
someone who is a woman… not that I wouldn't trust a
man to do that, but I think women have the ability, even
as doctors, to be more empathetic and, understand your
concerns with a medication that a man may brush off as
not being as strong of a concern.”—Participant 14
3.4 | Theme 4: Payment
As a whole, participants expected to have an associated fee for phar-
macist prescribing services, and this did not change their perceptions
of the service. Participants were willing to pay an average of $50
(range, $20–$100) for a pharmacist contraception-prescribing interac-
tion. Many participants questioned whether insurance coverage would
apply to this service.
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“It just depends on how much it costs. I think that insur-
ance should be able to cover it if you have insurance.”—
Participant 2
Regardless of whether insurance could be used, participants
expressed an expectation of an associated fee and a willingness to pay
for this service.
“I would think you would have to pay at least the minimal
fee, that is an actual service they are providing, and most
likely I would think extra training they have to get.”—
Participant 5
The last aspect of payment for pharmacist prescribing that
emerged was as a cost comparison to a provider visit. While participants
were willing to pay a fee for this service, they also felt it should be
more cost effective than a provider's office visit.
“I mean if it's $25, that would be great. But if it is $50, I
can go to my doctor for that.”—Participant 1
4 | DISCUSSION
Legislation allowing pharmacists to prescribe contraceptive medica-
tions does not currently exist in Indiana or in the majority of other
states, and currently in Indiana there is no legislation under consid-
eration for pharmacists to prescribe contraceptives. However,
CDTM laws make creation of a pharmacist contraceptive-
prescribing model possible in the absence of such legislation. In
considering how a pharmacist prescribing model using CDTM in
Indiana would be implemented, the women in this study provided
useful insight. The participants of this study perceived pharmacist
prescribing as a more convenient model than the model they are
currently utilizing to obtain contraception. As such, women are
willing to pay for the convenience, which warrants further investi-
gation in order to create a financially sustainable model. Another
key aspect to implementation would be ensuring that women are
aware of the training and qualifications of pharmacists to deliver a
contraceptive-prescribing service, as this was a common question
raised by participants. A structured training program would need
to be utilized for any pharmacist wishing to adopt this model.
Lastly, strong relationships with collaborating physicians would be
beneficial for the success of pharmacist contraceptive-prescribing
services. Many women expressed an increased comfort with phar-
macist prescribing if their current provider was included in commu-
nication. Development of a CDTM protocol requires an overseeing
provider that is willing to delegate responsibility to the pharmacist,
which could lead to a mutually collaborative relationship that can
serve to increase the comfort of women seeking services at the
pharmacy.
The majority of women who participated in this study would
personally utilize a pharmacist prescribing service for their
contraceptive needs, and all participating women expressed that
the service would be beneficial to others. Women are also willing
to pay a fee for the convenience of this service, which could sup-
port financially viable business models. This is important, because
pharmacists are not currently able to receive reimbursement from
health insurance providers for this or other clinical services. While
women expressed a willingness to pay an out-of-pocket fee, the
amount was limited based on comparison to the cost of attending
a traditional visit with their health care provider. While a patient's
co-payment for their provider visit may be $50, the actual cost of
the visit is significantly higher. Discussions surrounding payment
highlight the lack of understanding that many patients have sur-
rounding the true cost of health care services and the complex
reimbursement structure that exists.
As additional states continue to propose and pass pharmacist
contraception-prescribing legislation or pharmacists create CDTM
protocols for these medications,8,19 special consideration must be
given to the age of women eligible to receive services. Multiple
states currently restrict this service to women who are at least
18-years-old.20,21 However, women most at risk of unintended preg-
nancy are adolescents and young adults.2 Concerns related to paren-
tal consent were raised by participants of this study, as were
potential positive experiences for young women. While not voiced
during this study, the ability of adolescents to accurately recall their
own medical history and independently consent to medical treat-
ment is often a cited concern with the expansion of medical policy
to young people.22 Ongoing research continues to demonstrate that
adolescents have the ability and capacity to accurately self-screen
for appropriate use of hormonal contraception.22-24 Additional
research is needed, with consideration given for including this vul-
nerable population in any policies that enhance access to
contraception.
Several limitations exist for this study. The perceptions expressed
by participants might not be representative of those from women out-
side of central Indiana as the majority of participants were white, non-
Hispanic, and had health insurance. Perceptions of the health care
system might vary from women who have different demographic
characteristics. Recruitment methods could have potentially lead to
bias in participation as women with strong opinions about contracep-
tion access may have been more likely to respond to study informa-
tion posted in public areas.
5 | CONCLUSIONS
The results of this study suggest that women in central Indiana desire
broader access to contraception that is convenient, safe, and deliv-
ered by a professional who makes them feel comfortable. Efforts
should be made at the individual pharmacist-provider level and state-
wide to explore strategies to increase access to contraception, in line
with the HP2020 goals and objectives.1 Resources should be allocated
to the creation of CDTM protocols for pharmacist prescribing within
Indiana, as well as in other states.
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